Click Below to Find Out More About Our Services

  • Up to 99% detection of symptomatic bacterial, fungal, and viral pathogens, including pathogens that can not be detected with traditional culture and sensitivity. 

  • Pathogen and patient-specific antibiotic resistance information within 24 hours

  • Detects the presence of infection by amplifying pathogens RNA and DNA

  • Identifies polymicrobial infections

  • Provides accurate antibiotic use with antimicrobial resistance information

  • Easily access test orders and reports through the Stratus Portal

Horizon Diagnostic Laboratory's Infectious Disease PCR Testing Program Offers:

 
  • Information on the parent drug as well as the metabolites with descriptions of appropriate metabolite findings and drug detection windows. 

  • A higher sensitivity than Point-of-Care screening so low values of medication can be detected. 

  • Information to help Providers identify the potential for overdose or lethal medication combinations. 

  • Easily access test orders and reports through the Stratus Portal.

Horizon Diagnostic Laboratory's Urine Drug Testing Program Offers:

According to the CDC, 67,000 people died from drug overdoses in 2018. 70% of those deaths involved either a legal or illicit opioid. Concurrent use of opioid pain medications with other opioid pain medications, benzodiazepines, or heroin can increase patients’ risk for overdose. Urine drug tests can provide information about drug use that is not reported by the patient. In addition, urine drug tests can assist clinicians in identifying when patients are not taking opioids prescribed for them, which might in some cases indicate diversion or other clinically important issues such as difficulties with adverse effects. 

 

According to the CDC, millions of individuals are infected by antibiotic-resistant pathogens; accounting for over 35,000 deaths per year in the US and will account for 50 million deaths worldwide by 2050. Though there have been breakthroughs in the creation of new antibiotics, we currently cannot simply rely on the discovery of novel drugs. Rapid identification of antibiotic resistant genes in bacteria will become vital for health outcomes. Utilizing PCR technology, providers can prescribe the right antibiotic the first time.